Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

Clinical trial NCT04528082 · RECRUITING

Trial details

NCT number: NCT04528082
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Behçet Disease

Start date: 2021-09-09
Primary completion: 2030-02-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.